T-cell/Histocyte-rich Large B-cell Lymphoma
1 clinical trials · Condition
◉ Watch T-cell/Histocyte-rich Large B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas (NCT04933617) | National Cancer Institute (NCI) | 2022-03-24 |
Track T-cell/Histocyte-rich Large B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.